{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:30:34Z","timestamp":1777519834019,"version":"3.51.4"},"reference-count":122,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Psychiatry"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To summarize key characteristics and consequences of illicit opioid use from the literature and to present corresponding data from a multisite sample of illicit opioid users in 5 Canadian cities (OPICAN study).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>We undertook an overview of recent literature from North America, Australia, and Europe. We obtained data from the multicity OPICAN cohort study, which consisted of an interviewer-administered questionnaire, a standardized mental health instrument (the Composite International Diagnostic Interview Short Form for depression), and saliva-antibody tests for infectious disease (that is, HIV and hepatitis C virus). The baseline sample ( n = 679) was collected in 2002.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Illicit opioid use in Canada and elsewhere is becoming increasingly heterogeneous in terms of opioid drugs used, with heroin playing an increasingly minor role; further, it predominantly occurs in a context of polydrug use (for example, cocaine\u2013crack or benzodiazepines). Large proportions of illicit opioid users have physical and (or) mental health comorbidities, including infectious disease and (or) depression, and therefore require integrated interventions. Finally, morbidity risks among illicit opioid users are often predicted by social marginalization factors, for example, housing status or involvement in crime.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Given the epidemiologic profile and high disease burden associated with contemporary forms of illicit opioid use, more effective treatment approaches are urgently needed in Canada and elsewhere. Specifically, treatment must adjust to the extensive polysubstance use realities, yet it must also more effectively address the complex physical and (or) mental health comorbidities presented by this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/070674370605101002","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T05:46:18Z","timestamp":1484199978000},"page":"624-634","source":"Crossref","is-referenced-by-count":47,"title":["Illicit Opioid Use and its Key Characteristics: A Select Overview and Evidence from a Canadian Multisite Cohort of Illicit Opioid Users (OPICAN)"],"prefix":"10.1177","volume":"51","author":[{"given":"Benedikt","family":"Fischer","sequence":"first","affiliation":[{"name":"Director, Illicit Drugs, Public Health and Policy Unit, Centre for Addictions Research of British Columbia, Victoria, British Columbia; Associate Professor, University of Victoria, Victoria, British Columbia; Research Scientist, Public Health and Regulatory Policies Unit, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Firestone","family":"Cruz","sequence":"additional","affiliation":[{"name":"Research Coordinator, Public Health and Regulatory Policies Unit, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[{"name":"Senior Scientist and Section Head, Public Health and Regulatory Policies Unit, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario; Addiction Policy Chair and Professor, University of Toronto, Toronto, Ontario"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"bibr1-070674370605101002","volume-title":"Treating drug problems (Institute of Medicine. Volume 2)","author":"Courtwright D.","year":"1992"},{"key":"bibr2-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1007\/BF02344032"},{"key":"bibr3-070674370605101002","first-page":"66","volume-title":"reducing risks, promoting healthy life","author":"World Health Organization","year":"2002"},{"key":"bibr4-070674370605101002","unstructured":"Remis R, Leclerc P, Routledge R, Taylor C, Bruneau J, Beauchemin J, and others. Consortium to characterize injection drug users in Canada (Montreal, Toronto, and Vancouver). Final report. Toronto (ON): University of Toronto; 1998. p 1\u201374."},{"key":"bibr5-070674370605101002","first-page":"95","volume-title":"Beigebrauch: Offene grenzen der substitution","author":"Fischer B","year":"2000"},{"key":"bibr6-070674370605101002","unstructured":"The Office of National Drug Control Policy (ONDCP). Heroin fact sheet: June 2003. Available: www.whitehousedrugpolicy.gov\/publications\/factsht\/heroin\/. Accessed 2006 June 23."},{"key":"bibr7-070674370605101002","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2000.tb139321.x"},{"key":"bibr8-070674370605101002","volume-title":"Annual report 2005: The state of the drugs problem in Europe","author":"EMCDDA European Monitoring Centre for Drugs and Drug Addiction","year":"2005"},{"key":"bibr9-070674370605101002","doi-asserted-by":"publisher","DOI":"10.3109\/16066359909004395"},{"key":"bibr10-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.10.012"},{"key":"bibr11-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.05.009"},{"key":"bibr12-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00003-6"},{"key":"bibr13-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.05.004"},{"key":"bibr14-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1007\/BF03405190"},{"key":"bibr15-070674370605101002","volume-title":"Canadian Addiction Survey (CAS): A national survey of Canadians' use of alcohol and other drugs: Prevalence of use and related harms. A detailed report","author":"Adlaf E","year":"2005"},{"key":"bibr16-070674370605101002","volume-title":"OxyContin Task Force: Final report. Newfoundland and Labrador","author":"OxyContin Task Force","year":"2004"},{"key":"bibr17-070674370605101002","volume-title":"Statistical information on narcotic drugs: Part four","author":"International Narcotics Control Board","year":"2004"},{"key":"bibr18-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)00117-8"},{"key":"bibr19-070674370605101002","first-page":"894","volume":"166","author":"Spittal P","year":"2002","journal-title":"CMAJ"},{"key":"bibr20-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00236.x"},{"key":"bibr21-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199802010-00010"},{"key":"bibr22-070674370605101002","first-page":"889","volume":"165","author":"Patrick DM","year":"2001","journal-title":"CMAJ"},{"key":"bibr23-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1080\/01459740.2000.9966161"},{"key":"bibr24-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00058.x"},{"key":"bibr25-070674370605101002","doi-asserted-by":"publisher","DOI":"10.3109\/00952999609001650"},{"key":"bibr26-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1996.tb02289.x"},{"key":"bibr27-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9444712.x"},{"key":"bibr28-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/12.3.228"},{"key":"bibr29-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1080\/105504999305956"},{"key":"bibr30-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.95812178.x"},{"key":"bibr31-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00103-3"},{"key":"bibr32-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.941714.x"},{"key":"bibr33-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.9668476.x"},{"key":"bibr34-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00204-0"},{"key":"bibr35-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1086\/375566"},{"key":"bibr36-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2003.10400491"},{"key":"bibr37-070674370605101002","first-page":"259","volume":"33","author":"Razak MH","year":"2003","journal-title":"JAIDS"},{"key":"bibr38-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.9545698.x"},{"key":"bibr39-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00193-X"},{"key":"bibr40-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.1.272"},{"key":"bibr41-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1300\/J126v03n01_06"},{"key":"bibr42-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.03.012"},{"key":"bibr43-070674370605101002","volume-title":"Comparing injecting and noninjecting illicit opioid users in a multisite Canadian sample (OPICAN cohort)","author":"Fischer B"},{"key":"bibr44-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1994.tb00896.x"},{"key":"bibr45-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg209"},{"key":"bibr46-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.94811798.x"},{"key":"bibr47-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820190079008"},{"key":"bibr48-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg022"},{"key":"bibr49-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9357016.x"},{"key":"bibr50-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7129.426"},{"key":"bibr51-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1007\/BF03405100"},{"key":"bibr52-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jth128"},{"key":"bibr53-070674370605101002","volume-title":"A study to characterize the epidemiology of hepatitis C infection in Canada, 2002. Final report","author":"Remis R.","year":"2004"},{"key":"bibr54-070674370605101002","first-page":"197","volume":"29","author":"Geduld J","year":"2003","journal-title":"Can Commun Dis Rep"},{"key":"bibr55-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199802001-00004"},{"key":"bibr56-070674370605101002","first-page":"91","volume-title":"EMCDDA monographs: Hepatitis C and injection drug use: Impact, costs and policy options","author":"Wiessing L","year":"2004"},{"key":"bibr57-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200207001-00003"},{"key":"bibr58-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1159\/000018966"},{"key":"bibr59-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-32713"},{"key":"bibr60-070674370605101002","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0602"},{"key":"bibr61-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.014"},{"key":"bibr62-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.18.2370"},{"key":"bibr63-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-199706000-00009"},{"key":"bibr64-070674370605101002","doi-asserted-by":"publisher","DOI":"10.3109\/10673229709030550"},{"key":"bibr65-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.931738.x"},{"key":"bibr66-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-100101849"},{"key":"bibr67-070674370605101002","volume-title":"Textbook of substance abuse treatment","author":"Brady KT","year":"2004"},{"key":"bibr68-070674370605101002","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0902"},{"key":"bibr69-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2004.03.003"},{"key":"bibr70-070674370605101002","doi-asserted-by":"publisher","DOI":"10.3138\/cjcrim.43.2.197"},{"key":"bibr71-070674370605101002","volume-title":"Taking care of business: The economics of crime by heroin abusers","author":"Johnson B","year":"1985"},{"key":"bibr72-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198502000-00006"},{"key":"bibr73-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00107-0"},{"key":"bibr74-070674370605101002","doi-asserted-by":"publisher","DOI":"10.3109\/10826089209068755"},{"key":"bibr75-070674370605101002","doi-asserted-by":"publisher","DOI":"10.3109\/10826089809059325"},{"key":"bibr76-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1007\/BF01064593"},{"key":"bibr77-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00244.x"},{"key":"bibr78-070674370605101002","doi-asserted-by":"publisher","DOI":"10.3109\/00952999809001714"},{"key":"bibr79-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-38097"},{"key":"bibr80-070674370605101002","first-page":"37","volume-title":"Cost benefit analysis of heroin maintenance treatment","author":"Frei A","year":"2000"},{"key":"bibr81-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05356-2"},{"key":"bibr82-070674370605101002","doi-asserted-by":"publisher","DOI":"10.2307\/3343343"},{"key":"bibr83-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830050035005"},{"key":"bibr84-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1300\/J069v24n01_04"},{"key":"bibr85-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2005.09.010"},{"key":"bibr86-070674370605101002","unstructured":"Fischer B, Popova L, Rehm J, Ivsins A. Drug use related overdose mortality in British Columbia and Ontario, 1992\u20132002. Can J Public Health. Forthcoming."},{"key":"bibr87-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1007\/BF02190738"},{"key":"bibr88-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1159\/000081410"},{"key":"bibr89-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.09.004"},{"key":"bibr90-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.05.010"},{"key":"bibr91-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1007\/BF03405776"},{"key":"bibr92-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1081\/JA-120002807"},{"key":"bibr93-070674370605101002","first-page":"8","volume":"46","author":"Hunt D","year":"1984","journal-title":"NIDA Res Monogr"},{"key":"bibr94-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/79.4.571"},{"key":"bibr95-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1080\/09595230096093"},{"key":"bibr96-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(90)90005-B"},{"key":"bibr97-070674370605101002","unstructured":"CNW Group. First new opiate addiction treatment in over 40 years: Subutex(R) changes landscape for opiate addiction treatment. Available: www.newswire.ca\/en\/releases\/archive\/February2005\/11\/c3086.html. Accessed 2006 June 27."},{"key":"bibr98-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.13.4.293"},{"key":"bibr99-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.7.1025"},{"key":"bibr100-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.02.007"},{"key":"bibr101-070674370605101002","volume-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence (Cochrane Review). Cochrane Library 2","author":"Mattick R","year":"2004"},{"key":"bibr102-070674370605101002","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200523010-00007"},{"key":"bibr103-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00169-8"},{"key":"bibr104-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G276"},{"key":"bibr105-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/79.2.164"},{"key":"bibr106-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7410.310"},{"key":"bibr107-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1277"},{"key":"bibr108-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jti049"},{"key":"bibr109-070674370605101002","volume-title":"Using latent class analysis (LCA) to analyze patterns of drug use in a population of illicit opioid users","author":"Monga N","year":"2005"},{"key":"bibr110-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1024\/2005.04.04"},{"key":"bibr111-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1031416"},{"key":"bibr112-070674370605101002","doi-asserted-by":"crossref","unstructured":"Cruz M Firestone, Fischer B, Kalousek K, Newton-Taylor B, Rehm J, Tyndall M. Prevalence and associated factors of Hepatitis C infection (HCV) in a multisite Canadian population of illicit opioid and other drug users (OPICAN). 2006. Can J Public Health. Forthcoming.","DOI":"10.1007\/BF03404324"},{"key":"bibr113-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1177\/070674370505000903"},{"key":"bibr114-070674370605101002","unstructured":"Manzoni P, Brochu S, Fischer B, Rehm J. Determinants of property crime among illicit opiate users outside of treatment across Canada. Deviant Behav. Forthcoming."},{"key":"bibr115-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1080\/09595230120058588"},{"key":"bibr116-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17630-7"},{"key":"bibr117-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00416.x"},{"key":"bibr118-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1086\/427441"},{"key":"bibr119-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1086\/427447"},{"key":"bibr120-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1086\/427475"},{"key":"bibr121-070674370605101002","first-page":"S135","volume":"117","author":"Galea S","year":"2002","journal-title":"Public Health Rep"},{"key":"bibr122-070674370605101002","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200204000-00021"}],"container-title":["The Canadian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/070674370605101002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/070674370605101002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:09:42Z","timestamp":1777392582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/070674370605101002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":122,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1177\/070674370605101002"],"URL":"https:\/\/doi.org\/10.1177\/070674370605101002","relation":{},"ISSN":["0706-7437","1497-0015"],"issn-type":[{"value":"0706-7437","type":"print"},{"value":"1497-0015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}